The tyrosine-click reaction, utilizing 4-phenyl-3H-1,2,4-triazoline-3,5(4H)-diones (PTADs), represents a powerful strategy for chemoselective bioconjugation under mild aqueous conditions. This study demonstrates the broad utility of PTAD derivatives functionalized with azide, alkyne, and ketone groups for labeling peptides and proteins with high efficiency and specificity. The reaction proceeds rapidly at room temperature in phosphate-buffered saline (PBS) or Tris buffer, enabling applications across diverse pH ranges without requiring toxic metal catalysts. When applied to model peptides containing multiple reactive side chains—such as tyrosine, tryptophan, lysine, and histidine—the PTAD reagents selectively modified only the tyrosine residue, confirming exceptional chemoselectivity even in complex environments. Furthermore, sequential tri-functionalization of serum albumins was achieved by combining tyrosine-click chemistry with cysteine- and lysine-targeted labeling methods, resulting in fully conjugated, multi-labeled proteins with minimal cross-reactivity. A critical challenge identified was the potential decomposition of PTAD into a promiscuous isocyanate intermediate, which could lead to non-specific labeling. However, this issue was effectively mitigated by including small amounts of Tris buffer, which scavenges the isocyanate byproduct through its primary amine group. The resulting C–N linkage formed during the tyrosine-click reaction exhibited remarkable stability under extreme conditions, including prolonged exposure to human blood plasma, wide pH variations, and elevated temperatures—outperforming conventional maleimide-based linkages, which are prone to hydrolysis and retro-Michael reactions. These findings were validated through extensive chemical stability studies, including acid/base treatment, thermal stress, and plasma incubation assays, all showing no degradation of the PTAD-derived adducts. In practical applications, the method enabled site-specific PEGylation of chymotrypsinogen using a 5-kDa PEG-PTAD reagent, yielding predominantly mono-PEGylated products, in contrast to the heterogeneous mixtures typically obtained via lysine-targeted NHS-PEGylation.Copper(I) Purity & Documentation Most significantly, the tyrosine-click reaction was successfully employed to generate a novel antibody-drug conjugate by linking the HIV entry inhibitor aplaviroc to trastuzumab.CD79 ProteinSource The resulting conjugate retained potent HIV-1 neutralizing activity with an IC50 of 11.PMID:34864385 3 nM, comparable to free aplaviroc (5.6 nM), demonstrating that the conjugation process preserves biological function. Moreover, ELISA confirmed no loss in antibody binding affinity. Collectively, these results establish the PTAD-based tyrosine-click reaction as a robust, selective, and versatile platform for protein engineering, offering significant advantages over existing methods in the development of therapeutic conjugates, diagnostic probes, and functional biomaterials.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com